| Title |
Ongoing Challenges in Pharmacovigilance
|
|---|---|
| Published in |
Drug Safety, November 2013
|
| DOI | 10.1007/s40264-013-0123-x |
| Pubmed ID | |
| Authors |
Gerald J. Dal Pan |
| Abstract |
While pharmacovigilance systems have made substantial progress in the past several decades, all pharmacovigilance systems face a common set of ongoing challenges in drug safety surveillance in five principal interrelated areas: engaging the public, collaboration and partnerships, incorporating informatics, adopting a global approach, and assessing the impact of efforts. In broad terms, these challenges are not new. Rather, advances in science and technology, along with more demanding societal expectations, have changed the nature of these challenges and provided new opportunities to move the field forward. Differences in organization and levels of development, as well as regional differences, necessarily imply that a single approach is not suitable for all regions, though sharing of best practices can help each region. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| South Africa | 1 | <1% |
| Unknown | 129 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 38 | 29% |
| Student > Ph. D. Student | 19 | 15% |
| Student > Postgraduate | 9 | 7% |
| Student > Bachelor | 9 | 7% |
| Researcher | 7 | 5% |
| Other | 18 | 14% |
| Unknown | 30 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 29 | 22% |
| Medicine and Dentistry | 28 | 22% |
| Computer Science | 8 | 6% |
| Agricultural and Biological Sciences | 7 | 5% |
| Nursing and Health Professions | 5 | 4% |
| Other | 17 | 13% |
| Unknown | 36 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2015.
All research outputs
#6,127,772
of 22,731,677 outputs
Outputs from Drug Safety
#664
of 1,696 outputs
Outputs of similar age
#71,057
of 301,839 outputs
Outputs of similar age from Drug Safety
#4
of 13 outputs
Altmetric has tracked 22,731,677 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 1,696 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 301,839 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.